Francesco Ladisa

4PUBLICATIONS
39CO-AUTHORS
Gene and molecular therapyMicroelectromechanical systems (MEMS)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 09, 2026
CRISPR application in hematological disorders: from bench to bedside.

|Oct 17, 2025
ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3.

Mariateresa Fulciniti, Yao Yao, Tommaso Perini

|May 02, 2025
CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma.

Giulia Giorgetti, Elena Maroto-Martin, Debora Soncini

|Dec 11, 2024
NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma.

Debora Soncini, Pamela Becherini, Francesco Ladisa

Pageof 1

Frequent Collaborators

2 joint publications

Eugenio Morelli

2 joint publications

Giulia Giorgetti

2 joint publications

Mariateresa Fulciniti

2 joint publications

Nikhil C Munshi